WASHINGTON — The Trump administration is pushing pharmaceutical companies to begin negotiations to bring their drug prices in ...

Why did RFK Jr. abruptly fire all members of CDC's vaccine advisory panel? Vaccine expert Kathryn Edwards joins the podcast ...

Ridding the government, including CDC’s vaccine advisory committee, of industry interests should not play out this way, ...

A new study found some systematic reviews included retracted studies from paper mills, journals that produce low quality ...

Taxpayers will send an estimated $86 billion to Medicare Advantage insurers this year to pay for supplemental benefits for ...

The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a welcome win.

BioNTech said Thursday it would buy CureVac, its onetime competitor in the Covid-19 vaccine race, for about $1.25 billion in ...

Ousted CDC vaccine adviser says RFK Jr.’s message is clear: ‘Scientific expertise is no longer of use’ ...

A new $50 million NIH initiative to find the causes of autism faces questions about transparency and independence.

The future of the genetic data owned by 23andMe is uncertain as the company undergoes a court-supervised sale.

The Trump administration had said it would disclose by Wednesday the target prices for drugs, but pharma companies are still ...

Authors of a study published yesterday in JAMA Network Open surveyed more than 300 abortion providers about where they ...